Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
Abstract Background A meta-analysis of randomized controlled trials was recently published in BMC Surgery that compared the use of human albumin with 6% hydroxyethyl starches 130/0.4 for cardiopulmonary bypass prime and perioperative fluid management in pediatric and adult cardiac surgery patients....
Main Author: | Christian J. Wiedermann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-022-01588-x |
Similar Items
-
Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials
by: Christian Josef Wiedermann, et al.
Published: (2012-07-01) -
Comparison of Albumin, Hydroxyethyl Starch and Ringer Lactate Solution as Priming Fluid for Cardiopulmonary Bypass in Paediatric Cardiac Surgery
by: Jigar Patel, et al.
Published: (2016-06-01) -
Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann’s Solution
by: Corrin J. Boyd, et al.
Published: (2022-10-01) -
Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
by: Martin A. Schick, et al.
Published: (2021-11-01) -
Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
by: Katja-Nicole Adamik, et al.
Published: (2022-01-01)